13F HOLDINGS REPORT
BVF INC/IL
Quarter ended Q3 2023 · Filed August 14, 2023 · Accession 0000921895-23-001946
Total Value
$3.59B
Positions
67
Other Managers
1
Confidential Omitted
No
Holdings (67)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | MOONLAKE IMMUNOTHERAPEUTICS | MLTX | 21,751,284 | $1.11B | 30.92% |
| 2 | REVOLUTION MEDICINES INC | RVMDW | 6,255,588 | $167.3M | 4.66% |
| 3 | AXSOME THERAPEUTICS INC | AXSM | 2,131,100 | $153.1M | 4.27% |
| 4 | IDEAYA BIOSCIENCES INC | IDYA | 5,683,489 | $133.6M | 3.72% |
| 5 | IONIS PHARMACEUTICALS INC | IONS | 2,846,015 | $116.8M | 3.25% |
| 6 | GH RESEARCH PLC | GHRS | 9,275,158 | $110.0M | 3.07% |
| 7 | KYMERA THERAPEUTICS INC | KYMR | 4,739,004 | $108.9M | 3.04% |
| 8 | PROTAGONIST THERAPEUTICS INC | PTGX | 3,775,900 | $104.3M | 2.91% |
| 9 | POINT BIOPHARMA GLOBAL INC | 730541109 | 10,563,748 | $95.7M | 2.67% |
| 10 | GALAPAGOS NV | GLPGF | 2,165,109 | $88.0M | 2.45% |
| 11 | REPARE THERAPEUTICS INC | 760273102 | 8,291,988 | $87.7M | 2.45% |
| 12 | STRUCTURE THERAPEUTICS INC | GPCR | 1,750,000 | $72.7M | 2.03% |
| 13 | 4D MOLECULAR THERAPEUTICS IN | FDMT | 4,007,413 | $72.4M | 2.02% |
| 14 | KURA ONCOLOGY INC | KURA | 6,730,983 | $71.2M | 1.98% |
| 15 | XENON PHARMACEUTICALS INC | XENE | 1,827,958 | $70.4M | 1.96% |
| 16 | OLEMA PHARMACEUTICALS INC | OLMA | 7,611,503 | $68.7M | 1.92% |
| 17 | XOMA CORP DEL | XOMAP | 3,633,743 | $68.6M | 1.91% |
| 18 | CENTESSA PHARMACEUTICALS PLC | CNTA | 9,423,215 | $58.3M | 1.63% |
| 19 | ZYMEWORKS INC | ZYME | 5,870,000 | $50.7M | 1.41% |
| 20 | REPLIMUNE GROUP INC | REPL | 2,143,036 | $49.8M | 1.39% |
| 21 | JANUX THERAPEUTICS INC | JANX | 4,106,945 | $48.7M | 1.36% |
| 22 | TYRA BIOSCIENCES INC | TYRA | 2,739,595 | $46.7M | 1.30% |
| 23 | LEXICON PHARMACEUTICALS INC | LXRX | 19,995,332 | $45.8M | 1.28% |
| 24 | MERUS N V | N5749R100 | 1,602,420 | $42.2M | 1.18% |
| 25 | RELAY THERAPEUTICS INC | RLAY | 3,120,521 | $39.2M | 1.09% |
| 26 | ALLAKOS INC | 01671P100 | 8,652,417 | $37.7M | 1.05% |
| 27 | 89BIO INC | 282559103 | 1,846,154 | $35.0M | 0.98% |
| 28 | ACLARIS THERAPEUTICS INC | ACRS | 3,360,941 | $34.9M | 0.97% |
| 29 | CULLINAN ONCOLOGY INC | CGEM | 3,196,701 | $34.4M | 0.96% |
| 30 | ITEOS THERAPEUTICS INC | 46565G104 | 1,810,835 | $24.0M | 0.67% |
| 31 | ESSA PHARMA INC | 29668H708 | 8,748,629 | $23.6M | 0.66% |
| 32 | OVID THERAPEUTICS INC | OVID | 6,851,051 | $22.5M | 0.63% |
| 33 | AC IMMUNE SA | ACIU | 7,428,379 | $22.0M | 0.61% |
| 34 | THIRD HARMONIC BIO INC | 88427A107 | 4,365,933 | $21.0M | 0.59% |
| 35 | IKENA ONCOLOGY INC | 45175G108 | 3,169,164 | $20.8M | 0.58% |
| 36 | NEWAMSTERDAM PHARMA COMPANY | NAMSW | 1,521,948 | $18.1M | 0.50% |
| 37 | VIGIL NEUROSCIENCE INC | 92673K108 | 1,813,633 | $17.0M | 0.48% |
| 38 | GLYCOMIMETICS INC | 38000Q102 | 9,544,262 | $16.6M | 0.46% |
| 39 | SUTRO BIOPHARMA INC | STRO | 3,347,946 | $15.6M | 0.43% |
| 40 | JASPER THERAPEUTICS INC | JSPRW | 9,900,000 | $13.6M | 0.38% |
| 41 | AN2 THERAPEUTICS INC | ANTX | 1,563,963 | $13.3M | 0.37% |
| 42 | VERASTEM INC | VSTM | 1,685,219 | $12.5M | 0.35% |
| 43 | VERVE THERAPEUTICS INC | 92539P101 | 650,000 | $12.2M | 0.34% |
| 44 | CALLIDITAS THERAPEUTICS AB | 13124Q106 | 750,000 | $11.8M | 0.33% |
| 45 | CYTOMX THERAPEUTICS INC | CTMX | 6,595,801 | $11.3M | 0.32% |
| 46 | SILENCE THERAPEUTICS PLC | SLNCF | 1,508,416 | $8.3M | 0.23% |
| 47 | CIDARA THERAPEUTICS INC | 171757107 | 6,861,127 | $7.8M | 0.22% |
| 48 | TSCAN THERAPEUTICS INC | TCRX | 2,989,474 | $7.5M | 0.21% |
| 49 | DELCATH SYS INC | DCTH | 1,178,787 | $6.9M | 0.19% |
| 50 | NLS PHARMACEUTICS LTD | H57830103 | 5,747,126 | $6.3M | 0.18% |
| 51 | ARAVIVE INC | 03890D108 | 4,784,214 | $6.0M | 0.17% |
| 52 | ELEDON PHARMACEUTICALS INC | ELDN | 4,326,710 | $5.9M | 0.17% |
| 53 | VIRACTA THERAPEUTICS INC | 92765F108 | 3,614,662 | $5.1M | 0.14% |
| 54 | KRONOS BIO INC | 50107A104 | 2,813,485 | $4.8M | 0.13% |
| 55 | RAIN ONCOLOGY INC | 75082Q105 | 3,526,729 | $4.2M | 0.12% |
| 56 | ASLAN PHARMACEUTICALS LTD | 04522R200 | 1,049,999 | $3.8M | 0.11% |
| 57 | ELEVATION ONCOLOGY INC | 28623U101 | 2,312,200 | $3.5M | 0.10% |
| 58 | PIERIS PHARMACEUTICALS INC | 720795103 | 20,609,863 | $3.4M | 0.10% |
| 59 | CORVUS PHARMACEUTICALS INC | CRVS | 1,370,947 | $3.1M | 0.09% |
| 60 | IMMUNIC INC | IMUX | 1,149,425 | $2.9M | 0.08% |
| 61 | INVENTIVA SA | IVEVF | 686,040 | $2.8M | 0.08% |
| 62 | MOLECULAR PARTNERS AG | MOLN | 443,221 | $2.7M | 0.08% |
| 63 | MOLECULAR TEMPLATES INC | 608550109 | 4,996,565 | $2.4M | 0.07% |
| 64 | INFINITY PHARMACEUTICALS INC | 45665G303 | 6,353,645 | $1.3M | 0.04% |
| 65 | REZOLUTE INC | RZLT | 190,815 | $377,814 | 0.01% |
| 66 | GALMED PHARMACEUTICALS LTD | GLMD | 89,853 | $261,472 | 0.01% |
| 67 | BIONOMICS LIMITED | 09063M205 | 80,971 | $178,136 | 0.00% |